Jane Street’s Sana Biotechnology SANA Stock Holding History

Jane Street’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$59.6K	Buy	20,700 +2,900	+16%	+$11.4K	﹤0.01%	10901
2025 Q4	$72.4K	Sell	17,800 -700	-4%	-$3.13K	﹤0.01%	10352
2025 Q3	$65.7K	Sell	18,500 -8,400	-31%	-$30.4K	﹤0.01%	10272
2025 Q2	$73.4K	Buy	26,900 +2,200	+9%	+$4.54K	﹤0.01%	9075
2025 Q1	$41.5K	Buy	+24,700	New	+$69K	﹤0.01%	9043
2024 Q2	–	Sell	-40,000	Closed	-$400K	–	10095
2024 Q1	$400K	Buy	+40,000	New	+$300K	﹤0.01%	7089
2023 Q3	–	Sell	-173,300	Closed	-$1.03M	–	9282
2023 Q2	$1.03M	Buy	+173,300	New	+$999K	﹤0.01%	5140
2022 Q3	–	Sell	-11,300	Closed	-$73K	–	10364
2022 Q2	$73K	Buy	+11,300	New	+$72K	﹤0.01%	8797
2022 Q1	–	Sell	-12,900	Closed	-$200K	–	10937
2021 Q4	$200K	Sell	12,900 -300	-2%	-$5.78K	﹤0.01%	8817
2021 Q3	$297K	Buy	+13,200	New	+$277K	﹤0.01%	8205

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Jane Street's SANA Position: Q1 2026 in Review

Jane Street reduced its Sana Biotechnology (SANA) stake by 80% in Q1 2026, selling an estimated $2.11M and leaving 132,715 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #8656.

Jane Street first reported a position in SANA in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.72M in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Jane Street held 132,715 shares of Sana Biotechnology worth $382K as of Q1 2026.
Jane Street sold 536,169 Sana Biotechnology shares in Q1 2026, an estimated $2.11M.
Sana Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8656 holding.
Jane Street first reported a position in Sana Biotechnology in Q2 2022 and has held it in 15 quarters since.
Jane Street's Sana Biotechnology position peaked at $2.72M in Q4 2025.
202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.